Charles Schwab’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.4M Buy
3,596,980
+22,941
+0.6% +$29.3K ﹤0.01% 2438
2026
Q1
$4.07M Sell
3,574,039
-118,611
-3% -$146K ﹤0.01% 2487
2025
Q4
$4.65M Sell
3,692,650
-76,284
-2% -$106K ﹤0.01% 2488
2025
Q3
$5.84M Buy
3,768,934
+418,558
+12% +$575K ﹤0.01% 2365
2025
Q2
$4.42M Buy
3,350,376
+608,390
+22% +$832K ﹤0.01% 2375
2025
Q1
$4.55M Sell
2,741,986
-755,420
-22% -$1.24M ﹤0.01% 2307
2024
Q4
$5.14M Sell
3,497,406
-714,949
-17% -$1.09M ﹤0.01% 2325
2024
Q3
$6.28M Sell
4,212,355
-835,569
-17% -$1.24M ﹤0.01% 2255
2024
Q2
$6.31M Sell
5,047,924
-761,374
-13% -$987K ﹤0.01% 2250
2024
Q1
$6.97M Buy
5,809,298
+75,598
+1% +$75.7K ﹤0.01% 2170
2023
Q4
$8.66M Buy
5,733,700
+183,754
+3% +$266K ﹤0.01% 2064
2023
Q3
$8.88M Buy
5,549,946
+405,106
+8% +$738K ﹤0.01% 1976
2023
Q2
$11.2M Buy
5,144,840
+297,100
+6% +$465K ﹤0.01% 1865
2023
Q1
$7.08M Buy
4,847,740
+473,117
+11% +$609K ﹤0.01% 2044
2022
Q4
$5.47M Buy
4,374,623
+561,093
+15% +$884K ﹤0.01% 2170
2022
Q3
$7.21M Buy
3,813,530
+420,857
+12% +$995K ﹤0.01% 2023
2022
Q2
$8.58M Sell
3,392,673
-478,230
-12% -$1.39M ﹤0.01% 1920
2022
Q1
$13.3M Buy
3,870,903
+296,038
+8% +$1.05M ﹤0.01% 1791
2021
Q4
$17.2M Buy
3,574,865
+24,106
+0.7% +$97.6K 0.01% 1702
2021
Q3
$13M Sell
3,550,759
-90,897
-2% -$338K ﹤0.01% 1859
2021
Q2
$14.7M Buy
3,641,656
+26,314
+0.7% +$103K ﹤0.01% 1784
2021
Q1
$15.5M Buy
3,615,342
+87,078
+2% +$416K 0.01% 1707
2020
Q4
$13.9M Buy
3,528,264
+236,653
+7% +$988K 0.01% 1656
2020
Q3
$12.1M Buy
3,291,611
+564,203
+21% +$2.38M 0.01% 1548
2020
Q2
$9.3M Buy
2,727,408
+214,671
+9% +$481K ﹤0.01% 1697
2020
Q1
$3.37M Buy
2,512,737
+50,317
+2% +$78.8K ﹤0.01% 2035
2019
Q4
$3.62M Buy
2,462,420
+25,271
+1% +$42.3K ﹤0.01% 2190
2019
Q3
$5.09M Buy
2,437,149
+49,333
+2% +$101K ﹤0.01% 1946
2019
Q2
$5.83M Buy
2,387,816
+128,250
+6% +$280K ﹤0.01% 1898
2019
Q1
$5.9M Buy
2,259,566
+159,070
+8% +$482K ﹤0.01% 1900
2018
Q4
$6.32M Sell
2,100,496
-2,697
-0.1% -$9.14K ﹤0.01% 1760
2018
Q3
$7.28M Sell
2,103,193
-292,638
-12% -$1.55M ﹤0.01% 1839
2018
Q2
$11.3M Buy
2,395,831
+788,753
+49% +$2.99M 0.01% 1513
2018
Q1
$5.09M Buy
1,607,078
+45,074
+3% +$181K ﹤0.01% 1933
2017
Q4
$7.65M Sell
1,562,004
-4,429
-0.3% -$25.7K 0.01% 1658
2017
Q3
$10.7M Buy
1,566,433
+471,256
+43% +$2.97M 0.01% 1377
2017
Q2
$7.21M Buy
1,095,177
+189,438
+21% +$1.33M 0.01% 1576
2017
Q1
$7.25M Sell
905,739
-37,309
-4% -$314K 0.01% 1540
2016
Q4
$8.77M Buy
943,048
+89,242
+10% +$923K 0.01% 1355
2016
Q3
$9.04M Buy
853,806
+69,546
+9% +$693K 0.01% 1243
2016
Q2
$7.33M Sell
784,260
-299,202
-28% -$3.04M 0.01% 1292
2016
Q1
$11.3M Buy
1,083,462
+12,867
+1% +$118K 0.01% 965
2015
Q4
$10.8M Buy
1,070,595
+438,227
+69% +$4.39M 0.01% 966
2015
Q3
$5.32M Buy
632,368
+192,095
+44% +$2.54M 0.01% 1423
2015
Q2
$7.08M Sell
440,273
-235,593
-35% -$3.66M 0.01% 1302
2015
Q1
$9.58M Buy
675,866
+36,779
+6% +$479K 0.01% 1022
2014
Q4
$6.38M Buy
639,087
+21,753
+4% +$186K 0.01% 1251
2014
Q3
$5.25M Buy
617,334
+1,801
+0.3% +$15.8K 0.01% 1328
2014
Q2
$5.44M Buy
615,533
+9,400
+2% +$82.1K 0.01% 1331
2014
Q1
$5.65M Buy
606,133
+98,516
+19% +$864K 0.01% 1236
2013
Q4
$4.29M Buy
507,617
+28,246
+6% +$286K 0.01% 1393
2013
Q3
$4.38M Buy
479,371
+132,913
+38% +$1.07M 0.01% 1277
2013
Q2
$2.56M Buy
+346,458
New +$2.39M 0.01% 1594

Other funds holding OPK

Charles Schwab's OPK Position: Q2 2026 in Review

Charles Schwab increased its Opko Health (OPK) stake by 0.64% in Q2 2026, buying an estimated $29.3K and bringing the position to 3,596,980 shares worth $5.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

Charles Schwab first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.2M in Q4 2021. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Charles Schwab held 3,596,980 shares of Opko Health worth $5.4M as of Q2 2026.
  • Charles Schwab bought 22,941 Opko Health shares in Q2 2026, an estimated $29.3K.
  • Opko Health made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2438 holding.
  • Charles Schwab first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Opko Health position peaked at $17.2M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.